Zobrazeno 1 - 10
of 1 585
pro vyhledávání: '"35"'
Autor:
Lei Zhang, Yan-hui Yang, Yunfei Chen, Yueting Huang, Cuicui Lv, Renchi Yang, Huiyuan Li, Wenjie Liu, Mingen Lv, Feng Xue, Rongfeng Fu, Xiaofan Liu, Tiantian Sun, Xian Zhang, Wei Liu, Donglei Zhang
Publikováno v:
British Journal of Haematology. 169:278-285
Primary immune thrombocytopenia (ITP) is an autoimmune disorder. Interleukin-35 (IL35) can suppress T cell proliferation and elicit the development of inducible regulatory T cells (Tregs). Previous studies have shown decreased plasma IL35 levels and
Autor:
Andreas Rosenwald, Grzegorz Rymkiewicz, Anja Mottok, Michael Unterhalt, Sylvia Hartmann, Harald Holte, Lisa M. Rimsza, Eva Hoster, Christoph Thorns, German Ott, Martin Dreyling, David W. Scott, Wolfram Klapper, Hanneke C. Kluin-Nelemans, Hilka Rauert-Wunderlich, Olivier Hermine
Publikováno v:
British Journal of Haematology, 184(4), 616-624. Wiley
Mantle cell lymphoma (MCL) is still considered incurable and the course of the disease is highly variable. Established risk factors include the Mantle Cell Lymphoma International Prognostic Index (MIPI) and the quantification of the proliferation rat
Autor:
J. L. Gottschall, Nina Mufti, Salvador Rico, Anna Erickson, Neeta Rugg, N. Huang, Laurence Corash, Jose A. Cancelas, Anne North, Sharon Graminske, M. A. Schott
Publikováno v:
Vox Sanguinis. 112:210-218
Background and Objectives Pathogen reduction technology using amustaline (S-303) was developed to reduce the risk of transfusion-transmitted infection and adverse effects of residual leucocytes. In this study, the viability of red blood cells (RBCs)
Publikováno v:
Parasite immunology
The rodent intestinal nematode H.p.bakeri has played an important role in the exploration of the host-parasite relationship of chronic nematode infections for over six decades, since the parasite was first isolated in the 1950s by Ehrenford. It soon
Autor:
Daniela M. Cerqueira, Natália von Gal Milanezi, Patrícia Soares Wyant, Regina M.S. Amorim, Laura Sichero, Cláudia R. F. Martins, Tainá Raiol, Marcelo M. Brigido
Publikováno v:
Journal of Medical Virology. 81:685-692
More than 100 HPV types have been described, 13 of which are classified as high-risk due to their association with the development of cervical cancer. The intratype genomic diversity of HPV-16 and -18 has been studied extensively, while little data h
Autor:
Emida Mohamed, Vivek Ajit Singh, Cheng Har Yip, Anita Zarina Bustam, Puteri Shafinaz Abdul-Rahman, Siti Zawiah Omar, Onn Haji Hashim, Saeid Reza Doustjalali, Yeng Chen, Boon Kiong Lim, Nur Aishah Mohd-Taib
Publikováno v:
ELECTROPHORESIS. 29:2645-2650
A 35 kDa glycoprotein whose abundance was previously demonstrated to be enhanced in sera of patients with endometrial adenocarcinoma (n = 12), was isolated from pooled sera of three of the cancer patients using champedak galactose-binding lectin affi
Autor:
Gilbert, Cornut, Simon, Gagnon, Catherine, Hankins, Deborah, Money, Karina, Pourreaux, Eduardo L, Franco, François, Coutlée, Julio, Montaner
Publikováno v:
Journal of Medical Virology. 82:1168-1178
The L1 gene encodes for the major capsid protein of human papillomaviruses (HPV). There is limited information on the polymorphism of L1 for types related to HPV-16. This report explores the polymorphism of L1 in phylogenetically related types 31, 33
Autor:
Thomas Ming Swi Chang
Publikováno v:
Artificial Organs. 16:8-12
The first artificial cells were prepared 35 years ago. They contain biologically active materials. They are now being used in medicine and biotechnology. Artificial cells containing adsorbents are already a routine form of treatment in hemoperfusion.
Publikováno v:
Scandinavian Journal of Medicine & Science in Sports. 20:65-73
Biopsy samples were taken from the vastus lateralis muscle of seven male subjects pre- and post-35 days bed rest (BR). The myosin heavy chain (MHC) isoform distribution of the samples was determined by densitometry of MHC bands separated by sodium do
Autor:
Monica Bocchia, Sante Tura, Marina Buzzi, P. L. Zinzani, Francesco Lauria, Luigi Gugliotta, Donatella Raspadori, Robert Foa, D. Benfenati
Publikováno v:
European Journal of Haematology. 45:3-6
During the past 6 years, clinical trials employing alpha-interferon (alpha-IFN) in hairy cell leukemia (HCL) have shown dramatic improvement in the management of this disease. Complete remissions (CR), however, are relatively rare (10-15%) and a mino